ArticleVeterinary medicine and science2021
Seroprevalence and risk factors for foot-and-mouth disease in cattle in Baghlan Province, Afghanistan.
Article in Veterinary medicine and science, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
9 citing papers in PubMed.
- First Serological Evidence of Foot-and-Mouth Disease Virus (FMDV) Infection Among Sheep and Goats in Selected Districts of Central Bangladesh.Veterinary medicine and science · 2026Article
- Prevalence and Serotype Distribution of Foot and Mouth Disease (FMD) Virus in Asian Countries: A Systematic Review and Meta-Analysis.Veterinary medicine international · 2026Review
- Determination of risk factors for foot and mouth disease emergence in East Java, Indonesia.Open veterinary journal · 2025Article
- Exploring bovine brucellosis in Bangladesh: Current scenario and future outlook.Journal of advanced veterinary and animal research · 2024Review
- Foot-and-mouth disease virus dynamics in border areas of Pakistan with Afghanistan.Molecular biology reports · 2024Article
- The prevalence of foot-and-mouth disease in Asia.Frontiers in veterinary science · 2023Review
- Crossing the Line: Seroprevalence and Risk Factors for Transboundary Animal Diseases Along the Tanzania-Zambia Border.Frontiers in veterinary science · 2022Article
- Knowledge, Attitudes, and Practices (KAPs) of Farmers on Foot and Mouth Disease in Cattle in Baghlan Province, Afghanistan: A Descriptive Study.Animals : an open access journal from MDPI · 2021Article
- Seroprevalence and risk factors for foot-and-mouth disease in cattle in Baghlan Province, Afghanistan.Veterinary medicine and science · 2021Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
A serological study of 376 cattle from 198 herds and a concurrent survey of farmers were undertaken in 53 villages in Khinjan, Doshi and Puli Khumri districts of Baghlan province, Afghanistan to determine the seroprevalence of Foot and Mouth Disease (FMD) and to identify risk factors for seropositive herds. A total of 419 cases of FMD were reported by the farmers in the year preceding the survey. The animal-level population seroprevalence was estimated at 42.0% (95% CI, 37.0-47.2). The seroprevalence increased with age in the sampled cattle (<2 years - 30.4%, 2-6 years - 40.3% and >6 years - 52.2%). Herds were more likely to be seropositive if the farmers: had purchased cattle in the year prior to the survey (OR = 2.6; 95% CI, 1.37-4.97); purchased ruminants from unknown (potentially risky) sources (OR = 2.13; 95% CI, 1.13-4.03); and sold milk to the market (OR = 1.99; 95% CI, 1.09-3.63). Herds that had been vaccinated had a lower odds of being seropositive (OR = 0.33; 95% CI, 0.68-0.66). This was the first epidemiological study of FMD in Baghlan province and the findings provide valuable direction for disease control on FMD in this and other provinces in Afghanistan.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.